Israel's Zebra Medical gets FDA clearance for
mammography tool
Send a link to a friend
[July 27, 2020]
TEL AVIV (Reuters) - Zebra Medical Vision,
an Israeli medical imaging analytics company, said on Monday it received
clearance from the U.S. Food and Drug Administration for its mammography
technology.
|
|
 The company's latest cleared product uses artificial intelligence to
prioritize and identify suspicious mammograms.
The mammograms are automatically sent to Zebra's platform, where
they are processed and analysed for suspected breast lesions. The
HealthMammo product then returns its result to the radiologist.
It is the company's first oncology tool to receive FDA clearance.
[to top of second column] |
Zebra said its technology can help clear the backlog of mammograms that has
resulted from the coronavirus crisis, which forced many tests to be postponed or
cancelled.
(Reporting by Tova Cohen; Editing by Steven Scheer)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
